The global HIV diagnosis market is expected to reach USD 6.45 billion by 2028, at a CAGR of 12.35% during the forecast period 2021-2028. The market growth is attributed to the increasing number of HIV cases, the availability of advanced diagnostic technologies, and the supportive government initiatives for HIV/AIDS awareness. The increasing number of HIV cases is one of the major factors driving the market growth, as the need for diagnosis is increasing in order to reduce the mortality rate of HIV/AIDS patients.
HIV diagnosis is the process of determining if a person has been infected with the Human Immunodeficiency Virus (HIV). Diagnosis is typically done through a combination of laboratory tests that detect the presence of the virus in the body. These tests may include blood tests, urine tests, and/or physical examinations. A diagnosis of HIV is usually made after a person has been exposed to the virus, or if they have symptoms of the virus, such as swollen lymph nodes, fever, and/or night sweats.
The market is segmented based on product and geography. By product, the market is divided into ELISA kits, western blot kits, rapid tests, nucleic acid tests (NATs), and others. ELISA kits are the most widely used product due to their accuracy and cost-effectiveness.
View For More Information Click: https://www.thebrainyinsights.com
By region, North America HIV Diagnosis Market Share in 2020 was 39.71%. North America is expected to dominate the market during the forecast period. The region is home to some of the leading players in the market, such as Abbott Laboratories, F. Hoffmann-La Roche, and Becton Dickinson. The availability of advanced technologies and the presence of large patient population are some of the major factors driving the market growth in North America.
The Asia Pacific is projected to be the fastest-growing region in the market due to the increasing government initiatives for HIV/AIDS awareness. The increasing number of HIV cases in India and China is also expected to drive the market growth in the region.
The major players in the market are Abbott Laboratories, F. Hoffmann-La Roche, Becton Dickinson, Siemens Healthineers, Danaher Corporation, bioMérieux SA, Danaher Corporation, Cepheid, Hologic, Inc., and bioLytical Laboratories Inc.
